Medicine

Protective effect of bevacizumab against interstitial lung disease in non-squamous non-small-cell lung cancer: a nationwide target trial emulation study.

Chikako Iwai, Y. Kimura, H. Matsui, Kiyohide Fushimi, Hideo Yasunaga

2026.4.28LUNG CANCER

DOI: 10.1016/j.lungcan.2026.109429

Abstract

Abstract is not available.

Citation format

IWAI, Chikako, et al. Protective effect of bevacizumab against interstitial lung disease in non-squamous non-small-cell lung cancer: A nationwide target trial emulation study. LUNG CANCER, 2026, 217: 109429.